About nine out of 10 new cancer drugs successfully clear preclinical development hurdles, but then they fail in human clinical testing. A new partnership facilitated by SAIC-Frederick Inc. aims to help change that outcome. The partnership brings together The UC Davis Cancer Center, The Jackson Laboratory and the National Cancer Institute’s (NCI) Center for...
Read more »
|
|
|